Save time and get answers to complex questions with AI chat
Drugpatentwatch market analysis industry today?What's the recommended schedule for lurbinectedin side effect checks?The expiration date of the key patent for guselkumab?Is allopurinol expensive?Excipients list used in dexamethasone creams?
See the DrugPatentWatch profile for Kesimpta
Kesimpta (ofatumumab) is manufactured by Novartis.
In both major markets, Kesimpta’s development and commercialization are tied to Novartis as the drug’s manufacturer and brand holder.
Kesimpta is a biologic, so manufacturing can involve contract manufacturing sites for drug substance and drug product. However, the product’s manufacturer/brand owner associated with regulatory filings and marketed product information is Novartis.
For patent-related and ownership references around Kesimpta/ofatumumab, you can search DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Kesimpta :